
Status of the Biotech Salmon - Silvia Wulf
Talking Biotech with Dr. Kevin Folta
00:00
Why the FDA Approval Process Was So Long
There has been a lot of criticism about this, mostly social media outrage by non-experts. What were some of the most unfounded but frequent concerns that were levied by critics? And can you help our audience respond to them? Well, the criticisms originally targeted safety. It was clear to our critics that they really couldn't talk about safety because that sort of asked an answer. So labeling was a concern and then most recently, it's escape. There's no chance of escape. Even if there was, no one's ever proved harm. But the reality is we want to protect our salmon. And so we want to make sure that they are contained in that facility."
Transcript
Play full episode